Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients
Clinical trial NCT01309490 · TERMINATED
Trial details
- NCT number
- NCT01309490
- Sponsor
- Jewish General Hospital
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-17
- Primary completion
- 2014-10-29
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.